The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ezetimibe/Simvastatin 10 mg/40 mg tablets

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/180/002

Main Information

Trade NameEzetimibe/Simvastatin 10 mg/40 mg tablets
Active SubstancesEzetimibe
Dosage FormTablet
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/180/002

Group Information

ATC CodeC10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents
C10BA02 simvastatin and ezetimibe


License statusAuthorised
Licence Issued22/05/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0034-059-002
Interchangeable List DocumentPDF of Interchangeable List
« Back